Xin-yu Wang
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Risk-based triage strategy by extended HPV genotyping for women with ASC-US cytology.
Journal: Annals of medicine
Published: January 17, 2025
A potent new-scaffold androgen receptor antagonist discovered on the basis of a MIEC-SVM model.
Journal: Acta pharmacologica Sinica
Published: January 10, 2024
Computationally guided discovery of novel non-steroidal AR-GR dual antagonists demonstrating potency against antiandrogen resistance.
Journal: Acta pharmacologica Sinica
Published: October 28, 2022
Extended HPV Genotyping for Risk Assessment of Cervical Intraepithelial Neoplasia Grade 2/3 or Worse in a Cohort Study.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: December 14, 2021
Discovery of a novel nonsteroidal selective glucocorticoid receptor modulator by virtual screening and bioassays.
Journal: Acta pharmacologica Sinica
Published: November 16, 2021
Oncological and Reproductive Outcomes of Fertility-sparing Surgery in Women with Early-stage Epithelial Ovarian Carcinoma: A Multicenter Retrospective Study.
Journal: Current medical science
Published: March 10, 2020
The inhibition of UBC13 expression and blockage of the DNMT1-CHFR-Aurora A pathway contribute to paclitaxel resistance in ovarian cancer.
Journal: Cell death & disease
Published: May 22, 2017
TXNDC17 promotes paclitaxel resistance via inducing autophagy in ovarian cancer.
Journal: Autophagy
Published: January 22, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026